Studies suggest that these symptoms may be more severe or frequent early in the development of ovarian cancer and researchers are exploring ways to screen based on this recognition.Ovarian cancer is one of the most deadly cancers and the fifth leading cause of cancer death among women in the United States.
Women should know the signs and symptoms of this disease, and they need to listen to their bodies, Poynor said. The symptoms are persistent or individual should be discussed with a health professional.
The number of deaths from all causes was remarkably similar, with 2924 deaths among the screened women and 2914 deaths among women who were not screened. Screening: more harm than good?
Women screened every year and followed for up to 13 years died in similar proportions of ovarian cancer and other causes than women who were not screened.
Screening does not reduce disease-related death among women at average risk, but results in an increase in invasive medical procedures and the associated damage. That’s according to results of a large, long-awaited government-funded trial.
Surgery confirmed ovarian cancer in 388 women, 1080 women without cancer, but ended up having surgical procedures and 163, or about 15percent have severe complications as a result.
Because the symptoms if they occur, are often attributed to other conditions, the majority of women with ovarian cancer is diagnosed late in disease progression.
More than 3,000 women had additional assessments on the basis of test results and about half of these women underwent exploratory surgery.
Ovarian cancer is often called the silent killer, but there is a growing awareness that many women experience symptoms when the disease is still curable, Poynor said.
Gynecologic oncologist and pelvic surgeon Elizabeth A. Poynor, MD, Hospital of New York’s Lenox Hill, called the ovarian cancer screening test results disappointing but not unexpected. All Hope Not Lost
The women in the study had a medium risk and were between 55 and 74 at the time of registration. Half the women received screening for ovarian cancer and half did not.
If diagnosed early, before the cancer spreads beyond the ovary, the five-year survival rate for ovarian cancer is 90percent, compared to only 30percent in patients with advanced disease.
He added that women at high risk and medium risk who qualify for screening tests for ovarian cancer should consider joining one.
Poynor said more frequent screening with CA125 and ultrasound may benefit women at high risk of developing ovarian cancer because of family history.
And major advances in ultrasound imaging in recent years may be useful for screening all women.
The screening protocol included serum 125 (CA-125) blood tests for six years and a transvaginal ultrasound for four years.
All hope is not lost for these tools or for the diagnosis of ovarian cancer in general Poynor WebMD. We do not know how to use these for the moment, but that does not mean that should be discarded. What women can do
The problem is that many symptoms are common in women without ovarian cancer, including: back pain
More follow-up, which ended in late February 2010, ovarian cancer was diagnosed in 212 women in the screening group and 176 women who were not screened.
We need information, and these tests are the way they have it, he said.
These complications included infection, injury to the intestine, and cardiovascular events, Berg WebMD.
CA-125 is routinely used to monitor tumor progression in women with ovarian cancer, but its value for screening has long been in doubt because of the levels can increase with many other conditions, including endometriosis, pelvic inflammatory disease, and even menstruation and pregnancy.
In addition to being presented at the ASCO meeting, the study published in issue 8 June Journal of the American Medical Association.